Searchable abstracts of presentations at key conferences in endocrinology

ea0029p154 | Bone & Osteoporosis | ICEECE2012

Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women

Mok J. , Yu C. , Lee C.

Introduction: The study was a single-center, open label, randomized, head-to-head clinical study to compare the mucosal findings after perform esophagogastroduodenoscopy between two groups before and after use of alendronate only and enterocoating alendronate (5 mg) with calcitriol (0.5 μg) combined drug (Maxmarvil).Methods: The 33 postmenopausal healthy volunteers, aged 50–70 years (mean age: 58±5 years) without gastrointestinal symptoms ...

ea0029p1212 | Obesity | ICEECE2012

Regulation of adiponectin by free fatty acids in lean and obese subjects

Kim K. , Nam S. , Ahn C. , Yu J. , Kim K. , Cha B. , Lee H. , Richelsen B.

Objective: To evaluate the effects of free fatty acids (FFAs) on the regulation of plasma and adipose tissue mRNA adiponectin expression in lean and obese subjects.Methods: Seven obese men (31.3±1.1 kg/m2) and eight lean men (21.3±0.4 kg/m2) were studied. Subjects received an Intralipid 20% infusion over 180-min with sodium heparin. Blood sampling and abdominal subcutaneous adipose tissue biopsy were taken before and after...

ea0086p247 | Neuroendocrinology and Pituitary | SFEBES2022

Surgical management of prolactinomas in patients with dopamine agonist-associated impulse control disorders or who are deemed at ‘high risk’

T. C. Yu Arthur , Wernig Florian , Meeran Karim , Martin Niamh , Mendoza Nigel , Nair Ramesh , Jones Brynmor , Gontsarova Anastasia , Behary Preeshila

Introduction: Prolactinomas are the commonest type of secretory pituitary tumours. In current practice, dopamine agonists (DA) remain the mainstay treatment. However, treating physicians are increasingly aware of DA-associated impulse control disorders (ICD) in their patients. We describe 4 individuals with prolactinomas, who either developed ICD on DA or deemed at ‘high risk’, successfully managed surgically with preservation of pituitary function. All decisions for...